Stay updated on ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Sign up to get notified when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.

Latest updates to the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision notice was updated from Revision: v3.2.0 to Revision: v3.3.2 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedDeleted the notice about a lapse in government funding that warned information may not be up to date and directed users to opm.gov for status updates. The page no longer includes the operating status disclaimer or related guidance.SummaryDifference0.4%

- Check34 days agoChange DetectedThere are no significant changes between the old and new screenshots; the Study Details page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check69 days agoChange DetectedThe page now highlights Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a prior revision (v3.0.2), indicating a shift in content scope toward versioning rather than the previously listed safety topics.SummaryDifference0.4%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.